Pharmacokinetics of Meropenem in Preterm Neonates
- 1 June 2001
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Therapeutic Drug Monitoring
- Vol. 23 (3), 198-201
- https://doi.org/10.1097/00007691-200106000-00003
Abstract
The objective of this study was to evaluate and compare the pharmacokinetics of meropenem in premature neonates, both after the first dose and during steady state at day 5, after a 1-minute intravenous administration to evaluate the possibility of twice-daily administration. Seven premature neonates received 15 mg/kg meropenem twice daily on clinical grounds as a 1-minute infusion. After the first dose and during steady state at day 5, serum levels of meropenem were measured for 12 hours after intravenous administration. Meropenem pharmacokinetics at the first dose were studied in seven children (mean birth weight 925 g, mean postnatal age 21 days). Serum concentration–time curves could be described with a one-compartment model. Mean total body clearance was 0.157 L/kg per hour, volume of distribution was 0.74 L/kg, and half-life was 3.4 hours. At day 5 at steady state, pharmacokinetic properties did not differ significantly. No side effects were noted. A 1-minute intravenous administration is feasible. Pharmacokinetic properties are comparable at day 5 compared with the first dose, and half-life is such that twice-daily administration of 15 mg/kg produces adequate serum concentrations.Keywords
This publication has 7 references indexed in Scilit:
- Comparative Pharmacokinetics of the CarbapenemsClinical Pharmacokinetics, 2000
- A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes.European Journal of Drug Metabolism and Pharmacokinetics, 1997
- A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wideDiagnostic Microbiology and Infectious Disease, 1997
- Pharmacokinetics and renal function in preterm infantsActa Paediatrica, 1996
- Efficacy, safety and tolerability of meropenem as empiric antibiotic therapy in hospitalized pediatric patientsThe Pediatric Infectious Disease Journal, 1996
- Pharmacokinetic determinants of carbapenem therapy in neonates and childrenThe Pediatric Infectious Disease Journal, 1996
- MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoringComputers in Biology and Medicine, 1992